Tianze Jiao

Tianze Jiao, Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-9933
Business Email: tianzejiao@ufl.edu

About Tianze Jiao

Dr. Jiao accomplished his postdoctoral training at McGill University. Prior to it, he received his Ph.D. in Pharmacotherapy Outcomes Research & Health Policy from the University of Utah. He recently joined the Department of Pharmaceutical Outcomes & Policy as an Assistant Professor.

His research focuses on investigating and applying innovative and rigorous epidemiologic, economic, and comparative effectiveness research methods to identify and apply the precision medicine approach that will result in optimal outcomes for each patient in a resource-efficient manner. His goal is to investigate precision medicine that is both applicable for specific diseases and affordable, through the use of advanced study design (i.e. adaptive treatment strategy), cutting-edge statistical methods, and machine learning approaches adopting longitudinal Big Data. He has experience in multiple therapeutic areas with a focus on cardiology and pulmonology. As a principal investigator, currently, he is investigating the personalized optimal target blood pressure for patients with the hypertension-a project that is funded by the Canadian Institutes of Health Research.

Keywords: Pharmacoepidemiology, Big Data, Adaptive treatment strategy, Machine learning, Cardiology, Pulmonology

Teaching Profile

Courses Taught
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I


Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
Respiratory medicine. 198 [DOI] 10.1016/j.rmed.2022.106866. [PMID] 35594754.
Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.
Diabetes care. 45(8):1814-1821 [DOI] 10.2337/dc21-2601. [PMID] 35700384.
Predictors of Asthma Control and Exacerbations: A Real-World Study.
The journal of allergy and clinical immunology. In practice. 9(7):2802-2811.e2 [DOI] 10.1016/j.jaip.2021.04.049. [PMID] 33962067.
Prescription Patterns for the Use of Antihypertensive Drugs for Primary Prevention among Patients with Hypertension in the United Kingdom.
American journal of hypertension. [DOI] 10.1093/ajh/hpab137. [PMID] 34448818.
Real-world evidence in pain research: a review of data sources.
Journal of pain & palliative care pharmacotherapy. 28(3):294-304 [DOI] 10.3109/15360288.2014.941131. [PMID] 25136897.
Application of electronic medical record data for health outcomes research: a review of recent literature.
Expert review of pharmacoeconomics & outcomes research. 13(2):191-200 [DOI] 10.1586/erp.13.7. [PMID] 23570430.
Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillation.
Journal of managed care pharmacy : JMCP. 19(9):789-98 [PMID] 24156648.
A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
Journal of pain & palliative care pharmacotherapy. 26(2):153-64 [DOI] 10.3109/15360288.2012.671240. [PMID] 22509775.

Contact Details

(352) 273-9933
Business Mailing:
PO Box 100496